XV Chagas disease workshop – ISGlobal

14 March 2019
Barcelona, Spain

Organized by the Institute for Global Health Barcelona (ISGlobal), this workshop’s objective is to discuss the advances in antiparasitic treatment and care in people with Chagas disease. 

 

Presentations

Time: 11:30-12:10

Resultados del estudio BENDITA (Estudio Fase II con distintos esquemas terapeúticos de Benznidazol solo o combinado con pro-ravuconazol)
Fabiana BarreiraChagas Senior Clinical Manager, DNDi, Rio de Janeiro, Brasil

Time: 12.50- 13.30

Resultados del primer ensayo clínico con Fexinidazol en pacientes con enfermedad de Chagas 
Isabela Ribeiro, Head of Dynamic Portfolio Unit, DNDi

 

 

More information: